Across TCGA pan-cancer cohorts, BPY2B RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated BPY2B data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher BPY2B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BPY2B expression acts as an unfavorable survival marker.

ESCA are the cancer types where BPY2B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.198	0.872	.003	54	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: BPY2B tumor-vs-normal RNA expression · all BPY2B data types